Researchers found 18.5 million incident cases of cancer (excluding nonmelanoma skin cancers) and 10.4 million deaths in 2023.

There was a significant increase in the annual number of tested patients from 14,471 to 309,806 in 2015 and 2024, respectively.

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.

Men with HIV and severe sleep-disordered breathing experience the greatest sleep disruption, with lower efficiency, more light sleep, and unstable sleep stages.

HealthDay News — For community-dwelling older adults, late-life traumatic brain injury (TBI) is associated with higher rates of incident dementia and health care needs, according to a study published ...

Increased risk for incident clinical heart failure is associated with cognitive impairment, independent of cardiac function and other HF risk factors.

The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.

The White House has struck a deal with pharmaceutical giant Pfizer to lower the cost of prescription drugs for the Medicaid program.

Minimally invasive surgery did not significantly improve outcomes in patients with spontaneous supratentorial ICH compared with medical management alone.

The FDA has approved Bondlido (lidocaine topical system 10%) for the relief of pain associated with postherpetic neuralgia in adults.

Researchers associated factors with an increased risk for sudden unexpected death in epilepsy, including living alone.

NIBS may offer targeted therapeutic benefits for patients with ADHD, reducing inattention as well as hyperactivity and impulsivity symptoms.